Baillie Gifford & Co’s Vir Biotechnology VIR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,383,029	Closed	-$17.8M	–	283
2024 Q3	$17.8M	Sell	2,383,029 -1,538,213	-39%	-$13.4M	0.01%	186
2024 Q2	$34.9M	Sell	3,921,242 -25,823	-0.7%	-$248K	0.03%	156
2024 Q1	$40M	Sell	3,947,065 -18,484	-0.5%	-$188K	0.03%	156
2023 Q4	$39.9M	Sell	3,965,549 -6,022	-0.2%	-$55K	0.03%	163
2023 Q3	$37.2M	Sell	3,971,571 -11,874	-0.3%	-$169K	0.03%	159
2023 Q2	$97.7M	Sell	3,983,445 -2,581	-0.1%	-$64.8K	0.08%	124
2023 Q1	$92.8M	Buy	3,986,026 +1,425	+0%	+$36.4K	0.08%	123
2022 Q4	$101M	Buy	3,984,601 +5,944	+0.1%	+$146K	0.11%	111
2022 Q3	$76.7M	Buy	3,978,657 +47,805	+1%	+$1.22M	0.08%	128
2022 Q2	$100M	Sell	3,930,852 -16,308	-0.4%	-$381K	0.1%	121
2022 Q1	$102M	Buy	3,947,160 +31,659	+0.8%	+$939K	0.07%	138
2021 Q4	$164M	Buy	3,915,501 +15,809	+0.4%	+$619K	0.09%	118
2021 Q3	$170M	Buy	3,899,692 +50,183	+1%	+$2.17M	0.09%	122
2021 Q2	$182M	Buy	3,849,509 +32,361	+0.8%	+$1.47M	0.09%	128
2021 Q1	$196M	Buy	3,817,148 +72,200	+2%	+$3.89M	0.11%	117
2020 Q4	$100M	Buy	3,744,948 +29,060	+0.8%	+$945K	0.06%	131
2020 Q3	$128M	Buy	3,715,888 +252,686	+7%	+$10.9M	0.09%	112
2020 Q2	$142M	Buy	3,463,202 +3,333,333	+2,567%	+$112M	0.11%	103
2020 Q1	$4.45M	Sell	129,869 -370,131	-74%	-$9.95M	﹤0.01%	184
2019 Q4	$6.29M	Buy	+500,000	New	+$6.7M	0.01%	183